Clinical Trials Directory

Trials / Unknown

UnknownNCT05661513

Inventory of the Management of Acute Community-acquired Pneumonia in Strasbourg University Hospitals

Inventory of the Management of Acute Community-acquired Pneumonia in the Pneumology Department of the Strasbourg University Hospitals

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Acute community-acquired pneumonia (CAP) refers to an acute infection of the lung parenchyma, occurring within the first 48 hours of hospitalization. It is a frequent, serious pathology with a strong economic impact. Viruses (rhinovirus, respiratory syncitial virus, influenza virus for the most common) and Streptococcus pneumoniae are the most frequently encountered pathogens. However, more than half of the PACs have no microbiological documentation. The management of CAPs is based on national and international recommendations. Several studies have shown imperfect compliance by clinicians with recommendations with a prognostic impact. The various published studies insist on the variability of the incidence, the type of pathogen, the severity and the economic impact, depending on the series. They also insist on the need to know the local epidemiology, in particular microbiological, in order to adapt the recommendations.

Detailed description

The objective of the study is to determine the epidemiological, clinical, biological and imaging characteristics of people admitted for acute community-acquired pneumonia.

Conditions

Timeline

Start date
2022-09-09
Primary completion
2025-03-01
Completion
2025-03-09
First posted
2022-12-22
Last updated
2023-12-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05661513. Inclusion in this directory is not an endorsement.